Drug Discovery Services Market Highlights:

Drug Discovery Services refer to as the outsourcing the process of development of a new medicine. These services minimize the costs and timelines of drug discovery. The most common methods employed for drug discoveries are molecular manipulation, drug metabolites, random screening, molecular designing, and serendipity.

The Global Drug Discovery Services Market is growing at a rapid pace, mainly due to the burgeoning healthcare sector.  The market is predominantly driven by the augmented demand and supply for the medicines, the generic drugs, and the growing number of patents expires.

Additionally, factors such as increasing geriatric population, and technological advancements in the medicinal field escalating the market on the global level.

Acknowledging the ascending graph of the growth, the market is climbing constantly, Market Research Future (MRFR), The Drug Discovery Services Market Size was valued at USD 19.2 billion in 2022 and is projected to grow from USD 21.87 Billion in 2023 to USD 62.03 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.9% during the forecast period (2023 - 2032).

Drug Discovery Services Market – Geographical Analysis:

Globally the North American region dominates the drug discovery services market heading with the increasing consumption of medicines. This market is projected to grow at a strong CAGR, creating a large revenue pocket by the end of the review period. This is due to around the world. Also, factors such as the increasing prevalence of chronic diseases, high healthcare expenditures, and augmenting demand for the novel drug discoveries substantiates the growth of the drug discovery services market in the North American Region.

The European region accounts for the second-largest drug discovery services market share which is expected to grow at a considerable CAGR. The financial support by the government for research and development alongside the patent expiration of various blockbuster drugs are estimated to drive the drug discovery services market in the region. Furthermore, the burgeoning pharmaceutical industry fosters the growth of the regional market.

The Asia Pacific region is rapidly emerging as a promising market for drug discovery services owing to the availability of cost-competitive skilled workforce and raw materials. Factors such as the huge developments in the pharmaceutical sector, demand for breakthrough drug discoveries, and huge patient pool propels the market growth in the region.

Drug Discovery Services Market – Segments

MRFR has segmented the analysis into seven key dynamics for better understanding:

By Drug Type: small molecule drug discovery, and Biologics.

By Types of Services: Drug Metabolism & Pharmacokinetics (DMPK) Services, Pharmaceutical Services, Medicinal Chemistry, and Biological Services and others.

By Therapeutic Area: Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, and Diabetes among others.

By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation among others.

By Technology: High Throughput Screening, Biochips, Pharmacogenomics & Pharmacogenetics, Combinatorial Chemistry, Nanotechnology, Spectroscopy, and Metabolomics among others.

By End-user:  Hospitals & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institutes, among others.

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Drug Discovery Services Market Players

Some of the key players operating in the Drug Discovery Services Market Research are — Thermo Fisher Scientific INC. (US), Aragen Life Sciences Pvt. Ltd (India), Piramal Pharma Solutions (India), Curia Global, Inc. (US), Charles River Laboratories (US), Eurofins Scientific (Europe), IQVIA (US), Evotec (Germany), WuXi AppTec Co., Ltd. (China), Laboratory Corporation of America Holdings (US), Selvita (Poland), Sygnature Discovery (UK), Symeres (Netherlands), NuChem Sciences Inc (Canada), and Paraza Pharma, Inc. (Canada).

Key Services

The drug discovery services market encompasses a wide range of services, including:

1. Target Identification and Validation: Identifying and validating novel drug targets is the crucial first step in drug discovery. Service providers assist in selecting targets with therapeutic potential and conducting preliminary validations.
2. Hit Identification and Lead Optimization: High-throughput screening and computational methods help identify potential drug candidates (hits). Service providers optimize these hits to improve their drug-like properties, efficacy, and safety profiles.
3. ADME-Tox Profiling: Assessment of a drug candidate's absorption, distribution, metabolism, excretion, and toxicity (ADME-Tox) properties is vital for predicting its safety and efficacy. Service providers conduct comprehensive profiling to inform decision-making.
4. Biomarker Discovery: Biomarkers play a pivotal role in personalized medicine and clinical trial success. Drug discovery service providers contribute to biomarker identification and validation.
5. Chemical and Biological Synthesis: Expertise in chemical and biological synthesis is crucial for producing drug candidates and key intermediates. Service providers offer synthetic chemistry services for molecule synthesis.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com